Newsroom

Press Releases Events
Cystic Fibrosis News Today - Trial: BX004 reduces P. aeruginosa numbers with no signs of resistance
The Bio Report - Targeting Bacteria in Chronic Diseases
Contagion Live - What’s Old is New: Bacteriophage is a Therapy That May Combat Antimicrobial Resistance
BioCentury - Bacteriophage therapy for liver dysfunction
The Economist - Western firms are becoming interested in a Soviet medicine
Nature Biotechnology - Microbiome-friendly phages join the campaign for better antimicrobials
CF news today - Phage cocktail BX004 safe, seen to reduce P. aeruginosa in small trial
BioSpace - Boehringer Expands BiomX IBD Biomarker Collab, Shutters Crohn's Trial
BiomX Reports Third Quarter 2020 Financial Results and Announces Expanded Portfolio of Phage Therapy Candidates
BiomX Presents Preclinical Results of Phage Targeting Klebsiella pneumoniae for Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
Jefferies 2020 Virtual London Healthcare Conference

Sign up for the latest updates

Join our mailing list to receive company updates
delivered to your inbox Join the list

Reach Us

22 Einstein St., Floor 4
Ness Ziona 7414003
Israel

 +972-72-3942377

245 First Street, Riverview II,
Cambridge, Massachusetts 02142
USA